Please note a couple of important eligibility and budget updates for this Pfizer oncology opportunity. Clinical research projects are now explicitly listed as ineligible for funding. Additionally, keep in mind that you cannot use awarded funds to purchase Pfizer therapeutic agents.
Funder: Pfizer Inc.
Due Dates: April 15, 2026: Proposal due date / Full application submission deadline (by 23:59 Eastern Time, New York)
Funding Amounts: Up to C$100,000 per project; total program budget is C$300,000; project duration up to 24 months.
Summary: Supports Canadian research and quality improvement projects to enhance timely, equitable biomarker testing for colorectal cancer patients, especially metastatic CRC.
Key Information: Only organizations (not individuals) may apply; late applications will not be reviewed.